These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25550323)

  • 1. A 2-pyridone-amide inhibitor targets the glucose metabolism pathway of Chlamydia trachomatis.
    Engström P; Krishnan KS; Ngyuen BD; Chorell E; Normark J; Silver J; Bastidas RJ; Welch MD; Hultgren SJ; Wolf-Watz H; Valdivia RH; Almqvist F; Bergström S
    mBio; 2014 Dec; 6(1):e02304-14. PubMed ID: 25550323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolino 2-Pyridone Amide Inhibitors of Chlamydia trachomatis Infectivity.
    Good JA; Silver J; Núñez-Otero C; Bahnan W; Krishnan KS; Salin O; Engström P; Svensson R; Artursson P; Gylfe Å; Bergström S; Almqvist F
    J Med Chem; 2016 Mar; 59(5):2094-108. PubMed ID: 26849778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-pyridone amide inhibitor of transcriptional activity in
    Núñez-Otero C; Bahnan W; Vielfort K; Silver J; Singh P; Elbir H; Almqvist F; Bergström S; Gylfe Å
    Antimicrob Agents Chemother; 2023 May; 95(5):. PubMed ID: 33593835
    [No Abstract]   [Full Text] [Related]  

  • 4. Thiazolino 2-Pyridone Amide Isosteres As Inhibitors of Chlamydia trachomatis Infectivity.
    Good JAD; Kulén M; Silver J; Krishnan KS; Bahnan W; Núñez-Otero C; Nilsson I; Wede E; de Groot E; Gylfe Å; Bergström S; Almqvist F
    J Med Chem; 2017 Nov; 60(22):9393-9399. PubMed ID: 29053275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of the Chlamydia trachomatis inclusion does not require bacterial replication.
    Engström P; Bergström M; Alfaro AC; Syam Krishnan K; Bahnan W; Almqvist F; Bergström S
    Int J Med Microbiol; 2015 May; 305(3):378-82. PubMed ID: 25771502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane.
    Olson MG; Ouellette SP; Rucks EA
    J Proteomics; 2020 Feb; 212():103595. PubMed ID: 31760040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials.
    Shima K; Kaufhold I; Eder T; Käding N; Schmidt N; Ogunsulire IM; Deenen R; Köhrer K; Friedrich D; Isay SE; Grebien F; Klinger M; Richer BC; Günther UL; Deepe GS; Rattei T; Rupp J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity.
    Grieshaber S; Grieshaber N; Yang H; Baxter B; Hackstadt T; Omsland A
    J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic energy dependency of
    Liang P; Rosas-Lemus M; Patel D; Fang X; Tuz K; Juárez O
    J Biol Chem; 2018 Jan; 293(2):510-522. PubMed ID: 29123027
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic adaptation of Chlamydia trachomatis to mammalian host cells.
    Mehlitz A; Eylert E; Huber C; Lindner B; Vollmuth N; Karunakaran K; Goebel W; Eisenreich W; Rudel T
    Mol Microbiol; 2017 Mar; 103(6):1004-1019. PubMed ID: 27997721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: Design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analogues.
    Hwang J; Strange N; Phillips MJA; Krause AL; Heywood A; Gamble AB; Huston WM; Tyndall JDA
    Eur J Med Chem; 2021 Nov; 224():113692. PubMed ID: 34265463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage/Danger Associated Molecular Patterns (DAMPs) Modulate Chlamydia pecorum and C. trachomatis Serovar E Inclusion Development In Vitro.
    Leonard CA; Schoborg RV; Borel N
    PLoS One; 2015; 10(8):e0134943. PubMed ID: 26248286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host and Bacterial Glycolysis during
    Ende RJ; Derré I
    Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32900818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Protein Phosphatase CppA Alters Development of Chlamydia trachomatis.
    Claywell JE; Matschke LM; Plunkett KN; Fisher DJ
    J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30038048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel protease inhibitor causes inclusion vacuole reduction and disrupts the intracellular growth of Chlamydia trachomatis.
    Zhou Y; Lu X; Huang D; Lu Y; Zhang H; Zhang L; Yu P; Wang F; Wang Y
    Biochem Biophys Res Commun; 2019 Aug; 516(1):157-162. PubMed ID: 31202460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia trachomatis Oligopeptide Transporter Performs Dual Functions of Oligopeptide Transport and Peptidoglycan Recycling.
    Singh R; Liechti G; Slade JA; Maurelli AT
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32094256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose metabolism in Chlamydia trachomatis: the 'energy parasite' hypothesis revisited.
    Iliffe-Lee ER; McClarty G
    Mol Microbiol; 1999 Jul; 33(1):177-87. PubMed ID: 10411734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: the role of calmodulin.
    Murray A; Ward ME
    J Gen Microbiol; 1984 Jan; 130(1):193-201. PubMed ID: 6423768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host HDL biogenesis machinery is recruited to the inclusion of Chlamydia trachomatis-infected cells and regulates chlamydial growth.
    Cox JV; Naher N; Abdelrahman YM; Belland RJ
    Cell Microbiol; 2012 Oct; 14(10):1497-512. PubMed ID: 22672264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT295 Is
    Triboulet S; N'Gadjaga MD; Niragire B; Köstlbacher S; Horn M; Aimanianda V; Subtil A
    Front Cell Infect Microbiol; 2022; 12():866729. PubMed ID: 35795184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.